Niccoli P, Costagliola S, Patricot M C, Mallet B, Benahmed M, Carayon P
Laboratoire de Biochimie Endocrinienne et Métabolique, Unité 38 INSERM, Faculte de Médecine, Marseille, France.
J Endocrinol Invest. 1996 May;19(5):260-7. doi: 10.1007/BF03347861.
This report describes the results of the third part of the collaborative study organized by a working group sponsored by the Community Bureau of Reference of the European Community Commission. The aim of the present work was to establish the link between immunoreactivity and biological activity of human LH, thus allowing to determine the antigenic domains of the molecule involved in the induction of the biological effect. The relationship between immunoreactivity and electric charge of hLH was also studied. This work allowed to further apprehend hLH isomorphism and its role in discrepancies observed among hLH assays and clinical status. It also made the feasibility of measuring biologically active isoforms by an immunological method to be assessed. The effect of 36 mAb with known epitopic specificity, was evaluated on both hLH binding to rat membrane receptor and hLH induced production of testosterone by porcine Leydig cells. All the epitopes located on the beta subunit were found to be strongly involved in the biological activity whereas 4/9 and 10/18 epitopes present on the alpha subunit or specific for the holomolecule respectively appeared weakly involved. Assaying biological hLH using immunological method would require that mAb specific for all the epitopes involved in the receptor activation be tested, and thus appears presently unsuitable for routine clinical evaluation. In the previous work some LH immunoassays were found to underestimate LH concentrations (J. Endocrinol. Invest 1994, 17: 397-406 and 407-416). The mAb used in liquid phase in these kits were found in the present work to be directed against the domains of LH weakly involved in the activation of the receptor and would suggest that bioactive LH would be misevaluated by these kits. The immunoreactivity of hLH isoforms separated by isoelectric focusing (IEF) in liquid phase was also determined. IEF allowed to separate three groups of hLH isoforms but none of them exhibited a specific discriminating pattern of immunoreactivity when they were tested against a panel of mAb. It suggests that, in our experimental conditions, the electric charge and the immunoreactivity of hLH were not closely linked.
本报告描述了由欧洲共同体委员会参考局赞助的一个工作组组织的合作研究第三部分的结果。当前工作的目的是建立人促黄体生成素(LH)的免疫反应性与生物活性之间的联系,从而确定参与诱导生物效应的分子的抗原结构域。还研究了hLH的免疫反应性与电荷之间的关系。这项工作有助于进一步了解hLH的同质性及其在hLH检测结果差异和临床状况中所起的作用。它还评估了通过免疫方法测量生物活性异构体的可行性。评估了36种具有已知表位特异性的单克隆抗体(mAb)对hLH与大鼠膜受体结合以及hLH诱导猪睾丸间质细胞产生睾酮的影响。发现所有位于β亚基上的表位都与生物活性密切相关,而分别存在于α亚基上或对完整分子特异的4/9和10/18表位似乎与生物活性的相关性较弱。使用免疫方法检测生物活性hLH需要测试针对受体激活所涉及的所有表位的特异性mAb,因此目前似乎不适用于常规临床评估。在之前的工作中,发现一些LH免疫测定法低估了LH浓度(《内分泌学研究杂志》1994年,17: 397 - 406和407 - 416)。在本研究中发现,这些试剂盒中在液相中使用 的mAb针对的是LH中与受体激活相关性较弱的结构域,这表明这些试剂盒可能会错误评估生物活性LH。还测定了通过等电聚焦(IEF)在液相中分离的hLH异构体的免疫反应性。IEF能够分离出三组hLH异构体,但当用一组mAb对它们进行检测时,没有一组表现出特定的免疫反应性鉴别模式。这表明,在我们的实验条件下,hLH的电荷与免疫反应性没有紧密联系。